Clinical Data Access Fee Clause Samples
Clinical Data Access Fee. In consideration for the transfer of Clinical Data from four (4) Trial Subjects from INSERM to LICENSEE and the access to Clinical Data granted to LICENSEE pursuant to the License Agreement and this Amendment No. 2, LICENSEE shall pay to INSERM-TRANSFERT the total sum of [***]. Invoices are to be submitted to LICENSEE by email to: [***]. Installments will be paid within thirty (30) days of receipt of an invoice as follows:
(i) [***];
(ii) [***];
(iii) [***], and
(iv) [***].”
Clinical Data Access Fee. In consideration for the transfer of Clinical Data from two (2) Trial Subjects from INSERM to LICENSEE and the access to Clinical Data granted to LICENSEE pursuant to the License Agreement, LICENSEE shall pay to INSERM-TRANSFERT the total sum of [***]. Invoices are to be submitted to LICENSEE by email to: [***]. Installments will be paid within thirty (30) days of receipt of an invoice as follows:
(i) [***]
(ii) [***]
(iii) [***]
(iv) [***] Should more than two Trial Subjects (or their legal representatives) execute the Informed Consent Form, additional Clinical Data Access Fees shall be owed by LICENSEE, amounting to fifty percent (50%) of the payments listed under (i) to (iv) hereabove per additional Trial Subject. For the purpose of this Subsection 5.1.2 and of the payments under (ii) and (iii) above, LICENSEE shall promptly inform INSERM TRANSFERT by e-mail upon ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇'▇ first access (a) to the CRFs for the Original Period and (b) to the Clinical Data listed under Exhibit Α collected up to the Clinical Data Transfer Effective Date.
3. Subsection 11.4 of ARTICLE 11 - CLINICAL DATA ACCESS, of the License Agreement is hereby amended and restated in its entirety as follows: